An Open-Label, Multicentre Pilot Study of Bosentan in Pulmonary Arterial Hypertension Related to Congenital Heart Disease

An Open-Label, Multicentre Pilot Study of Bosentan in Pulmonary Arterial Hypertension Related to Congenital Heart Disease

BACKGROUND: Bosentan has been shown to be a safe and efficacious treatment for idiopathic pulmonary arterial hypertension (PAH) and PAH associated with connective tissue disease. However, there are limited studies examining the benefits of bosentan in PAH associated with congenital heart disease (CH...

Full description

Bibliographic Details
Main Authors: Reda Ibrahim, John T Granton, Sanjay Mehta
Format: Article
Language:English
Published: Hindawi Limited 2006-01-01
Series:Canadian Respiratory Journal
Online Access:http://dx.doi.org/10.1155/2006/746176
id doaj-f5c51c1b683c4dc9a97b207d8be44b49
record_format Article
spelling doaj-f5c51c1b683c4dc9a97b207d8be44b492021-07-02T10:28:24ZengHindawi LimitedCanadian Respiratory Journal1198-22412006-01-0113841542010.1155/2006/746176An Open-Label, Multicentre Pilot Study of Bosentan in Pulmonary Arterial Hypertension Related to Congenital Heart DiseaseReda Ibrahim0John T Granton1Sanjay Mehta2Montreal Heart Institute, University of Montreal, Montreal, Quebec, CanadaToronto General Hospital, University of Toronto, Toronto, CanadaThe Centre for Critical Illness Research, Lawson Health Research Institute, London Health Sciences Centre, University of Western Ontario, London, Ontario, CanadaBACKGROUND: Bosentan has been shown to be a safe and efficacious treatment for idiopathic pulmonary arterial hypertension (PAH) and PAH associated with connective tissue disease. However, there are limited studies examining the benefits of bosentan in PAH associated with congenital heart disease (CHD).http://dx.doi.org/10.1155/2006/746176
collection DOAJ
language English
format Article
sources DOAJ
author Reda Ibrahim
John T Granton
Sanjay Mehta
spellingShingle Reda Ibrahim
John T Granton
Sanjay Mehta
An Open-Label, Multicentre Pilot Study of Bosentan in Pulmonary Arterial Hypertension Related to Congenital Heart Disease
Canadian Respiratory Journal
author_facet Reda Ibrahim
John T Granton
Sanjay Mehta
author_sort Reda Ibrahim
title An Open-Label, Multicentre Pilot Study of Bosentan in Pulmonary Arterial Hypertension Related to Congenital Heart Disease
title_short An Open-Label, Multicentre Pilot Study of Bosentan in Pulmonary Arterial Hypertension Related to Congenital Heart Disease
title_full An Open-Label, Multicentre Pilot Study of Bosentan in Pulmonary Arterial Hypertension Related to Congenital Heart Disease
title_fullStr An Open-Label, Multicentre Pilot Study of Bosentan in Pulmonary Arterial Hypertension Related to Congenital Heart Disease
title_full_unstemmed An Open-Label, Multicentre Pilot Study of Bosentan in Pulmonary Arterial Hypertension Related to Congenital Heart Disease
title_sort open-label, multicentre pilot study of bosentan in pulmonary arterial hypertension related to congenital heart disease
publisher Hindawi Limited
series Canadian Respiratory Journal
issn 1198-2241
publishDate 2006-01-01
description BACKGROUND: Bosentan has been shown to be a safe and efficacious treatment for idiopathic pulmonary arterial hypertension (PAH) and PAH associated with connective tissue disease. However, there are limited studies examining the benefits of bosentan in PAH associated with congenital heart disease (CHD).
url http://dx.doi.org/10.1155/2006/746176
work_keys_str_mv AT redaibrahim anopenlabelmulticentrepilotstudyofbosentaninpulmonaryarterialhypertensionrelatedtocongenitalheartdisease
AT johntgranton anopenlabelmulticentrepilotstudyofbosentaninpulmonaryarterialhypertensionrelatedtocongenitalheartdisease
AT sanjaymehta anopenlabelmulticentrepilotstudyofbosentaninpulmonaryarterialhypertensionrelatedtocongenitalheartdisease
AT redaibrahim openlabelmulticentrepilotstudyofbosentaninpulmonaryarterialhypertensionrelatedtocongenitalheartdisease
AT johntgranton openlabelmulticentrepilotstudyofbosentaninpulmonaryarterialhypertensionrelatedtocongenitalheartdisease
AT sanjaymehta openlabelmulticentrepilotstudyofbosentaninpulmonaryarterialhypertensionrelatedtocongenitalheartdisease
_version_ 1721332068029300736

Similar Items